Prosperity Bancshares (PB)
(Delayed Data from NYSE)
$59.39 USD
+0.16 (0.27%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $59.40 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Price, Consensus and EPS Surprise
PB 59.39 +0.16(0.27%)
Will PB be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PB
Analysts Estimate Prosperity Bancshares (PB) to Report a Decline in Earnings: What to Look Out for
Prosperity Bancshares (PB) Completes Lone Star Acquisition
PB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Prosperity Bancshares (PB) is a Top Dividend Stock for Your Portfolio
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
Provident (PFS) & Lakeland (LBAI) Get Conditional Nod for Merger
Other News for PB
PROSPERITY BANCSHARES, INC.® ANNOUNCES COMMON STOCK DIVIDEND
Prosperity Bancshares declares $0.56 dividend
PB Crosses Below Key Moving Average Level
Amylyx down 6% despite encouraging phase 2 data on rare disorder drug
RBC Capital Sticks to Its Hold Rating for Prosperity Bancshares (PB)